SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001358403-15-000055
Filing Date
2015-07-16
Accepted
2015-07-16 16:10:34
Documents
3
Period of Report
2015-07-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K q32015form8-knewdirector.htm 8-K 35931
2 EXHIBIT 99.1 q32015pressreleasenewdirec.htm EX-99.1 9895
3 COMPANY LOGO logoa02.jpg GRAPHIC 12685
  Complete submission text file 0001358403-15-000055.txt   64778
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 15991635
SIC: 2834 Pharmaceutical Preparations